End Stage Liver DIsease
Conditions
Keywords
Transplants, Transplantation, Healthcare Disparities, Minority Health, Communication
Brief summary
The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.
Detailed description
Aim 1. Establish a longitudinal cohort of patients with end-stage liver dysfunction. Aim 2. Examine interpersonal and structural factors associated with liver transplant evaluation and listing by patient characteristics (e.g., race, ethnicity, SES, gender). Aim 3. Examine the use of stigmatizing language among patients undergoing liver transplant based on their demographic characteristics (e.g., race, ethnicity, SES, gender).
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
\- Patients with end-stage liver, kidney, or cardiac dysfunction.
Exclusion criteria
* Patients with more than one system with end stage organ dysfunction, dementia, cognitive or sensory impairment, prior solid organ transplant. * Patients with potential medical exclusions for transplant.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Liver transplant waiting list | Approximately one year | Number of subjects listed on the liver transplant waiting list |
| Organ transplantation | Approximately one year | Number of subject to receive an organ transplantation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Graft survival at six months | Six months post transplant | Total number of subject to have a functioning graft at six months post transplant |
| Graft survival at one year | One year post transplant | Total number of subject to have a functioning graft at one year post transplant |
| Survival | Approximately one year post-transplant, or until you are removed from the transplant list | Total number of subject alive |
Countries
United States
Contacts
Mayo Clinic